Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pulmonary arterial hypertension.

Srinivas Murali1

  • 1Drexel University College of Medicine, Allegheny General Hospital, Pittsburgh, Pennsylvania 15212, USA. smurali@wpahs.org

Current Opinion in Critical Care
|May 5, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Advancing quality in post-acute cardiovascular and stroke care: Why national leadership and certification matter.

The American journal of medicine·2026
Same author

Post-acute cardiovascular and stroke care and the potential of certification programs: A 'Call to Action'.

The American journal of medicine·2026
Same author

Prescription patterns of statins in cirrhotic patients: a survey among primary care physicians and cardiologists.

Proceedings (Baylor University. Medical Center)·2024
Same author

Integrating molecular and clinical variables to predict myocardial recovery.

bioRxiv : the preprint server for biology·2024
Same author

Cost Analysis of Remote Cardiac Rehabilitation Compared With Facility-Based Cardiac Rehabilitation for Coronary Artery Disease.

The American journal of cardiology·2023
Same author

Cable Tension Optimization for an Epicardial Parallel Wire Robot.

Journal of medical devices·2023

Pulmonary arterial hypertension treatments are shifting to targeted therapies. Future strategies may combine treatments and use pharmacogenetics for personalized care.

Area of Science:

  • Cardiology
  • Pulmonology
  • Pharmacology

Background:

  • Pulmonary arterial hypertension (PAH) prevalence is increasing globally.
  • Understanding PAH pathobiology has shifted treatment from vasodilators to targeted molecular therapies.
  • This review covers recent PAH treatment advances and future directions.

Purpose of the Study:

  • To review recent advances in pulmonary arterial hypertension treatment.
  • To provide insights into future directions for pulmonary arterial hypertension care.

Main Methods:

  • Review of current literature on pulmonary arterial hypertension treatments.
  • Analysis of prospective, randomized, controlled trials.

Main Results:

Related Experiment Videos

  • Endothelin-1 induction and reduced nitric oxide/prostacyclin transcription cause pulmonary vasoconstriction and vascular remodeling.
  • Endothelin receptor antagonists, prostanoids, and phosphodiesterase-5 inhibitors show benefits in PAH patients.
  • Future strategies may involve combining therapies for synergistic effects.

    • Conclusions:

    • Treatment guidelines emphasize evidence-based approaches for pulmonary arterial hypertension.
    • Pharmacogenetics holds promise for tailoring cost-effective treatments based on genetic variations in PAH patients.